Enzymatica’s business is exposed to several risks, both operational and financial risks.

The operational risks mainly comprise uncertainty concerning product development, supplier agreements, regulatory permits, product liability and distribution, and in addition, sales as a consequence of the pandemic. The financial risks primarily consist of currency, interest, price, credit and liquidity risks.

For a more detailed description of the risks and uncertainties Enzymatica faces, please see page 51-52 in our Swedish annual report.https://www.enzymatica.se/investerare/finansiella-rapporter/

Enzymatica cares about your privacy and processes your personal data in accordance with the EU’s General Data Protection Regulation. For more information about how we handle your personal information, and what rights you have, please refer to our personal data processing document here.